TA
Last reporting period 31 Mar, 2024
Updated —
Last price
—
Market cap $B
1.615
Exchange
XNYS - New York Stock Exchange, Inc
3.6
Last period Current ratio
-55%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Taro Pharmaceutical
Company Analysis
TARO valuation, rating, competitors, insights and company profile
Eyestock Rating
TARO financial analysis by Eyestock methodology
Valuation
TARO valuation using historical relative method
Statements
TARO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
TARO dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Taro Pharmaceutical`s Current ratio for the last twelve months ended 2024-03-31 is 3.6
